← back to search

Birgitte Vrou Offersen

Institute of Clinical Research · DK
Area of research
Cancer Research · Radiation
Research interest
Research interests include Breast Cancer Treatment Studies, Advanced Radiotherapy Techniques, Breast Implant and Reconstruction, and Breast Lesions and Carcinomas.
h-index
44
citations
7,071
works
229
NIH funding
primary concept
Medicine
email

Recent publications

A Genome-Wide Association Study on Radiation Induced Fibrosis in Breast Cancer Patients
2026cited by 0position: contributordoi
Association between shoulder joint radiation dose and arm morbidity in the randomized breast cancer trial SENOMAC.
2026cited by 0position: contributordoi
Validation of the ESTRO target volume consensus guideline for early-stage breast cancer in the DBCG Skagen Trial 1
Radiotherapy and Oncology 2026cited by 0position: contributordoi
A genome-wide association study on radiation induced fibrosis in breast cancer patients
Clinical and Translational Radiation Oncology 2026cited by 0position: contributordoi
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.
2025cited by 5position: contributordoi
Recommendations for radiotherapy quality assurance in clinical trials
Radiotherapy and Oncology 2025cited by 5position: contributordoi
What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?
Radiotherapy and Oncology 2025cited by 5position: contributordoi
Sustainable radiation oncology in a world with grand environmental and societal challenges: Society Matters - A new section in the Green Journal.
2025cited by 4position: contributordoi
Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of view
European Journal of Surgical Oncology 2025cited by 3position: contributordoi
Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1.
2025cited by 2position: contributordoi
Local recurrence with and without a tumour-bed boost: A post-hoc analysis of the DBCG IMN2 study
Radiotherapy and Oncology 2025cited by 2position: contributordoi
Patient reported respiratory symptoms and lung radiation doses 11 years after loco-regional breast cancer radiation therapy in the DBCG RT Nation Study
Acta Oncologica 2025cited by 1position: contributordoi
BiGART 2025 - the 25th Acta Oncologica Symposium.
2025cited by 0position: contributordoi
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
The Breast 2024cited by 184position: middledoi
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations
The Lancet Oncology 2024cited by 75position: middledoi
Residual breast tissue after mastectomy and reconstruction: A substudy of the Spatial location of breast cancer local rECurRence aftEr masTectomy (SECRET) project
European Journal of Surgical Oncology 2024cited by 4position: contributordoi
EUSOMA quality indicators for non-metastatic breast cancer: An update
European Journal of Cancer 2023cited by 44position: middledoi
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
Radiotherapy and Oncology 2023cited by 27position: lastdoi
Clinical research for global needs of radiation oncology
Radiotherapy and Oncology 2023cited by 7position: middledoi
Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic.
2023cited by 5position: contributordoi
Are hybrid conferences the new standard?
Radiotherapy and Oncology 2023cited by 2position: middledoi
Think big-think BiGART. The 21st Acta Oncologica Symposium-BiGART 2023.
2023cited by 1position: contributordoi
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study.
2022cited by 58position: contributordoi
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
The Breast 2022cited by 55position: middledoi
Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial.
2022cited by 52position: contributordoi
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
European Journal of Cancer 2022cited by 40position: middledoi
Personalised radiation therapy taking both the tumour and patient into consideration
Radiotherapy and Oncology 2022cited by 18position: middledoi
The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice
Radiotherapy and Oncology 2022cited by 11position: firstdoi
Reply to Y. Lu et al and E. Hindié et al.
2022cited by 0position: contributordoi
A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management
Radiotherapy and Oncology 2021cited by 12position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 20 papers (2020–2026)Jens Overgaard · WinnMed13 papers (2020–2026)Mechthild Krause · German Cancer Research Center12 papers (2015–2023)Philip Poortmans · Ziekenhuisnetwerk Antwerpen Stuivenberg9 papers (2015–2025)Liesbeth Boersma · Maastro Clinic8 papers (2015–2025)Marianne Aznar · Manchester Academic Health Science Centre7 papers (2015–2023) · 7 papers (2022–2026)David Thwaites · The University of Sydney6 papers (2020–2023)Michaël Baumann · European CanCer Organisation6 papers (2015–2023)Jan Alsner · Aarhus University Hospital6 papers (2020–2026)Robert P. Coppes · University Medical Center Groningen6 papers (2020–2025)Karin Haustermans · Peter MacCallum Cancer Centre5 papers (2020–2023)Steffen Löck · German Cancer Research Center5 papers (2020–2023)Éric Lartigau · Centre National de la Recherche Scientifique5 papers (2020–2023) · 5 papers (2021–2025) · 5 papers (2020–2026)Carol Bacchus · University of Calgary5 papers (2020–2023)Vincenzo Valentini · University Hospital Carl Gustav Carus5 papers (2020–2023)Éric Deutsch · Inserm5 papers (2020–2023)Peter Hoskin · Manchester Academic Health Science Centre5 papers (2020–2023)